Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Smoking cessation drug with liver and lung healing effect and preparation method thereof

A technology for efficacy and production of Aracea, applied to medical preparations containing active ingredients, pharmaceutical formulas, active ingredients of aluminum/calcium/magnesium, etc., can solve problems such as poor smoking cessation effect and aggravated lung lesions

Inactive Publication Date: 2019-06-25
甘肃大德行中医药有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The present invention provides a smoking cessation drug with liver and lung healing effects. Through the ancient prescription for smoking cessation, through the analytical reconstruction and scientific compatibility of the drug compatibility, it can solve the problem that the existing traditional Chinese medicine for smoking cessation has early mild lesions in the lungs of smokers Under the influence of smoking cessation, the effect of smoking cessation is poor and it is easy to cause the aggravation of lung lesions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] A smoking cessation medicine with liver and lung healing effect, comprising 15 parts by weight of saponins, 15 parts of gypsum, 10 parts of arachis, 10 parts of raw pinellia, 10 parts of anemarrhena, 15 parts of bupleurum, and flavescens 15 parts, 15 parts of tangerine peel, 10 parts of skullcap, 20 parts of turmeric, 20 parts of wine rhubarb, 15 parts of ginger, 20 parts of scorpion; also includes 10 pieces of jujube.

Embodiment 2

[0081] A smoking cessation medicine with liver and lung healing effect, comprising 25 parts of saponins, 30 parts of gypsum, 15 parts of arachis, 10 parts of raw pinellia, 15 parts of anemarrhena, 20 parts of bupleurum, and flavescens in parts by weight 20 parts, 20 parts of tangerine peel, 15 parts of skullcap, 30 parts of turmeric, 30 parts of wine rhubarb, 15 parts of ginger, 25 parts of scutellaria; 15 jujubes are also included.

Embodiment 3

[0083] A smoking cessation medicine with liver and lung healing effect, comprising 18 parts by weight of saponins, 20 parts of gypsum, 11 parts of arachis, 10 parts of raw pinellia, 12 parts of anemarrhena, 16 parts of bupleurum, and sophora flavescens 17 parts, 16 parts of tangerine peel, 11 parts of skullcap, 21 parts of turmeric, 23 parts of wine rhubarb, 15 parts of ginger, 22 parts of scorpion; also includes 12 pieces of jujube.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a smoking cessation drug with a liver and lung healing effect. The drug comprises saponin, gypsum, processed rhizoma arisaematis, pinellia, rhizoma anemarrhenae, bupleurum, sophora flavescens, dried tangerine peel, scutellaria baicalensis, radix curcumae, wine-treated rhubarb, ginger, trichosanthes kirilowii maxim and jujube. The drug is characterized in that an erchen decoction and a three-yellow liquor are combined to serve as a basic formula and combined with the rhizoma anemarrhenae and the wine-treated rhubarb to promote excretion together, achieve rapid effectivereduction of lung deposition, reduce the secondary damage of toxins to the lungs and avoid aggravation of the existing lung diseases. Combined with the effect of anti-inflammatory sterilization of the sophora flavescens, the ginger and the trichosanthes kirilowii maxim are compounded to achieve the effects of expanding the chest and removing stasis for smokers with early liver and lung diseases.The drug not only achieves treatment and elimination of the liver and lung diseases, but also enhances the effect of other components on liver and lung detoxification and distension dissolution, thereby significantly shortening the smoking cessation treatment and effects of the smokers and can cure the liver and lung diseases of the smokers. The smoking cessation drug can be prepared as a decoction, powder, a light pill or a heavy pill according to different preparation methods, and is suitable for the smoking cessation demand of different smoking people.

Description

technical field [0001] The invention relates to the technical field of smoking cessation and withdrawal prevention, in particular to a smoking cessation medicine with liver and lung healing effects and a preparation method thereof. Background technique [0002] my country is a big country in tobacco production and consumption, with more than 300 million smokers, and the annual cigarette consumption exceeds 40% of the world's cigarette consumption. According to estimates by the Chinese Academy of Preventive Medicine, about 400 million people are harmed by passive smoking to varying degrees. [0003] The burning smoke of cigarettes contains harmful substances such as carbon monoxide, tar, nicotine, etc. With the oxygen content of the body's circulatory system, and so on. It can be seen that smoking is not only harmful to the health of the smoker itself, but also threatens or harms the second-hand smoke inhalers of passive smoking at all times. Therefore, smoking cessation is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61K9/14A61K9/20A61P25/34A61P1/16A61P11/00A61K33/06
Inventor 贾智权周宜宣
Owner 甘肃大德行中医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products